Oxygen saturation and perfusion changes during dermatological methylaminolaevulinate photodynamic therapy

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1323-1331

  Tyrrell, J ^a   Thorn, C ^a   Shore, A ^a   Campbell, S ^a   Curnow, A ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN;

ADULT; AGED; ARTICLE; BLEACHING; BLOOD OXYGEN TENSION; CELL DEATH; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FLUORESCENCE; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REFLECTOMETRY; SCINTIGRAPHY; SKIN DISEASE; SKIN TEMPERATURE; TEMPERATURE DEPENDENCE; TISSUE OXYGENATION; TISSUE PERFUSION;

AGED, 80 AND OVER; AMINOLEVULINIC ACID; FEMALE; HUMANS; MALE; MICROCIRCULATION; OXYGEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN; SKIN DISEASES; SKIN TEMPERATURE;

EID: 82255175237     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10554.x     Document Type: Article

References (41)

1. Henderson BW, Dougherty TJ,. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-57.
2. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997; 65: 235-51. (Pubitemid 27158805)
3. Luna MC, Ferrario A, Wong S, et al. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res 2000; 60: 1637-44. (Pubitemid 30183436)
4. Malik Z, Lugaci H,. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 1987; 56: 589-95. (Pubitemid 17165652)
5. Calzavara-Pinton PG, Venturini M, Sala R,. Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 2007; 21: 293-302.
6. Fuchs J, Thiele J,. The role of oxygen in cutaneous photodynamic therapy. Free Radic Biol Med 1998; 24: 835-47. (Pubitemid 28169571)
7. Henderson BW, Fingar VH,. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987; 47: 3110-14. (Pubitemid 17082632)
8. Busch TM,. Local physiological changes during photodynamic therapy. Lasers Surg Med 2006; 38: 494-9.
9. Chen Q, Huang Z, Chen H, et al. Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol 2002; 76: 197-203.
10. Tromberg BJ, Orenstein A, Kimel S, et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 1990; 52: 375-85.
11. Mitchell JB, McPherson S, DeGraff W, et al. Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells. Cancer Res 1985; 45: 2008-11. (Pubitemid 15024376)
12. Moan J, Sommer S,. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985; 45: 1608-10. (Pubitemid 15079112)
13. Busch TM, Hahn SM, Evans SM, et al. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol- 1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]. Cancer Res 2000; 60: 2636-42. (Pubitemid 30318238)
14. Curnow A, Haller JC, Bown SG,. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B 2000; 58: 149-55. (Pubitemid 32117880)
15. Pogue BW, O'Hara JA, Goodwin IA, et al. Tumor PO(2) changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp Biochem Physiol A Mol Integr Physiol 2002; 132: 177-84. (Pubitemid 34327748)
16. Henderson BW, Gollnick SO, Snyder JW, et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 2004; 64: 2120-6. (Pubitemid 38339462)
17. Sitnik TM, Hampton JA, Henderson BW,. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer 1998; 77: 1386-94. (Pubitemid 28190737)
18. Busch TM, Wileyto EP, Emanuele MJ, et al. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res 2002; 62: 7273-9. (Pubitemid 36025249)
19. Robinson DJ, de Bruijn HS, van der Veen N, et al. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 1999; 69: 61-70. (Pubitemid 129555462)
20. Thompson MS, Johansson A, Johansson T, et al. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. Appl Opt 2005; 44: 4023-31. (Pubitemid 40971995)
21. Enejder AM, af Klinteberg C, Wang I, et al. Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging. Acta Derm Venereol (Stockh) 2000; 80: 19-23. (Pubitemid 30110842)
22. Schacht V, Szeimies RM, Abels C,. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application. Photochem Photobiol Sci 2006; 5: 452-8. (Pubitemid 43725965)
23. Herman MA, Fromm D, Kessel D,. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. J Photochem Photobiol B 1999; 52: 99-104. (Pubitemid 30011501)
24. Tyrrell J, Campbell SM, Curnow A,. The validation of a non-invasive fluorescence imaging system to monitor clinical dermatological photodynamic therapy. Photodiagnosis Photodyn Ther 2010; 7: 86-97.
25. Tyrrell J, Campbell S, Curnow A,. Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy. Photodiagnosis Photodyn Ther 2010; 7: 232-8.
26. Thorn CE,. The Regulation of Cutaneous Microvascular Haemodynamics as Determined by Optical Reflectance Spectroscopy; The Role of Vasomotion. PhD Thesis, Peninsula Postgraduate Health Institute. Exeter: Universities of Exeter and Plymouth, 2008; 281.
27. Meglinsky IV, Matcher SJ,. Modelling the sampling volume for skin blood oxygenation measurements. Med Biol Eng Comput 2001; 39: 44-50. (Pubitemid 32118109)
28. Merschbrock U, Hoffmann J, Caspary L, et al. Fast wavelength scanning reflectance spectrophotometer for noninvasive determination of hemoglobin oxygenation in human skin. Int J Microcirc Clin Exp 1994; 14: 274-81.
29. Palsson S, Gustafsson L, Bendsoe N, et al. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid. Br J Dermatol 2003; 148: 1179-88. (Pubitemid 36819218)
30. Caspary L, Thum J, Creutzig A, et al. Quantitative reflection spectrophotometry: spatial and temporal variation of Hb oxygenation in human skin. Int J Microcirc Clin Exp 1995; 15: 131-6.
31. Tyrrell J, Campbell SM, Curnow A,. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Photodiagnosis Photodyn Ther 2011; 8: 30-8.
32. Henderson BW, Busch TM, Snyder JW,. Fluence rate as a modulator of PDT mechanisms. Lasers Surg Med 2006; 38: 489-93.
33. Thorn CE, Matcher SJ, Meglinski IV, et al. Is mean blood saturation a useful marker of tissue oxygenation? Am J Physiol Heart Circ Physiol 2009; 296: H1289-95.
34. He C, Agharkar P, Chen B,. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy. Pharm Res 2008; 25: 1873-80.
35. Yu G, Durduran T, Zhou C, et al. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res 2005; 11: 3543-52. (Pubitemid 40627910)
36. Bedlow AJ, Stanton AWB, Cliff S, et al. Basal cell carcinoma-an in-vivo model of human tumour microcirculation? Exp Dermatol 1999; 8: 222-6. (Pubitemid 29256307)
37. O'Grady A, O'Kelly P, Murphy GM, et al. COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals. Hum Pathol 2004; 35: 1549-55. (Pubitemid 40017997)
38. Newell B, Bedlow AJ, Cliff S, et al. Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry. Br J Dermatol 2003; 149: 105-10. (Pubitemid 36966518)
39. McIlroy BW, Mann TS, Dysart JS, et al. The effects of oxygenation and photosensitizer substrate binding on the use of fluorescence photobleaching as a dose metric for photodynamic therapy. Vib Spectrosc 2002; 28: 25-35. (Pubitemid 34291393)
40. Dysart JS, Patterson MS,. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochem Photobiol Sci 2006; 5: 73-81.
41. Kruijt B, van der Ploeg-van den Heuvel A, de Bruijn HS, et al. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy. Lasers Surg Med 2009; 41: 653-64.